Alexandria Venture Investments has participated in an $88.9m round which has pushed the biotech developer's total funding past $142m.
US-based life science technology developer Invaio Sciences completed an $88.9m series C round on Tuesday featuring Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities.
Venture capital firm Flagship Pioneering led the round, which also featured Stage 1 Ventures and Bluwave Capital. The company said it has now raised over $142m to date.
Founded by Flagship Pioneering in 2018, Invaio is developing technology and services to address critical issues in agriculture, nutrition and…
